The difficulty with this answer, lies in the fact that not all of land and ocean biomes have been completely explored. The ocean is vast, covering approximately 70% of the Earth's surface, with literally vertical miles or kilometers of depth, and with some areas with sparse to no biodiversity. The same can be said about certain areas of large deserts with very low levels of biodversity, void of life, like vast deserts of the Sahara or Gobi. But, the Amazon rain forest contains still unknown species of plant and animal life, just like the ocean. Because of its vastness, intellectually, I would say the ocean contains more biodiversity, but the answer is scientifically, as of now, yet to be proven one way or the other.
Answer:
The beak size will either increase or decrease, depending on the past evolution.
Explanation:
An animal category is a gathering of creatures that can breed together that can deliver fruitful prosperity.
Ligers, Mules, They aren't species, they are a mix of 2 animal groups subsequently the name is half and half, they can't recreate in light of the fact that, the two distinct species have two unique quantities of chromosomes. Species can duplicate inside of their own species, since every person inside of the species has the same number of chromosomes.
The crossover's can't imitate in light of the fact that sex cells would never be prepared as their chromosomes would not be right. The half breeds would never happen in nature, they were made by man, I don't know how they fulfilled this, yet, at any rate, thats why the mixtures can't replicate.
Answer:
Explanation:
The more similar the two species are, the more their niche overlaps and the more competition there is.
<em>The most interesting results obtained in animal models of passive immunotherapies developed according to the “amyloid-beta cascade hypothesis” and the “Tau hypothesis” are monoclonal antibodies that directly or indirectly target Aβ plaques or neurofibrillary tangles. Unfortunately, these therapeutic antibodies cannot replicate their promising effects on humans at the clinical phase. Despite this, we still hope to learn from these failures and to explore new pathways. The great effects obtained in animals with passive immunotherapy suggest that this technology may be an important key to curative treatment. The remaining challenge is to find a way to achieve the same encouraging results for humans. Alzheimacy expects to join hands with global partners to focus on the development of therapeutic antibodies for Alzheimer’s disease (AD) and continue to fight against this disease.</em>
<em>https://www.creativebiomart.net/alzheimacy/therapeutics/therapeutic-antibody/</em>
Answer:
(especially of a person) having a jaw that does not project or recede so that the facial profile is nearly vertical
Explanation:
its my brainliest answer
i think it could help
